Merck drug data suggest 'new direction' for rare blood vessel disease
BioPharma
Marius Hoeper Merck Research Laboratories Hannover Medical School Merck Co New England Journal Clinical Trials
Source: biopharmadive.com
📰 Marius Hoeper News
Marius Hoeper News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Marius Hoeper. Real-time updates on events, politics, business and more.
Merck's Investigational Activin Signaling Inhibitor Sotatercept Improved Six-Minute Walk Distance by 40.8 Meters at Week 24 Versus Placebo in Adults with Pulmonary Arterial Hypertension on Background Therapy
Sotatercept demonstrated statistically significant improvements in 8 of 9 secondary measures, including reduction in risk of clinical worsening or deathResults presented today at ACC.23/WCC and published in The New England Journal of MedicineRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD o...
United States Julie Cunningham Marius Hoeper Peter Dannenbaum Damini Chokshi Merck Research Laboratories
Source: pharmiweb.com
Setting a course for progress in respiratory medicine
On Aug 26, 2022, the European Society of Cardiology and the European Respiratory Society published new guidelines for the diagnosis and treatment of pulmonary hypertension. Numerous factors are associated with the development of pulmonary hypertension, which has an estimated prevalence of around 1% globally, increasing to 10% in individuals older than 65 years, and is associated with worsening symptoms—including dyspnoea, fatigue, and syncope—and substantially increased mortality. The guidel...
Xavier Ja Takashi Kawakami Marius Hoeper European Respiratory Society European Society Of Cardiology Lancet Commission
Source: thelancet.com